Introduction
The prevalence of overweight or obese adults is on the rise in Europe, the United States, and China. Based on a body mass index (BMI) of ≥25 kg/m 2 , the prevalence of overweight Chinese adults was 29.2% in 2009. The prevalence of obesity in US adults ≥60 years was approximately 37% in 2010. Moreover, it has been estimated that 20%-30% of Europeans in the older age group will be obese in 2015 (1) (2) (3) . Progressively more domestic and international research is paying close attention to the correlation between weight and reproductive health, especially with respect to the negative effects of being overweight and obese on health. Some studies have reported that obesity and metabolic syndrome have effects on benign prostatic hyperplasia, male hypogonadism, male sexual function and infertility, and prostate cancer. In addition, age and BMI have been identified as risk factors for chronic prostatitis and chronic pelvic pain syndrome (4, 5) . There is an apparent correlation between BMI, sexual behavior, and sexual health (6) . Furthermore, being overweight and obese negatively influences clinical pregnancy and live birth rates after IVF treatment (7, 8) ; however, at present the association between BMI, semen quality, and male fertility is controversial (9) (10) (11) . Thus, the age, BMI, and semen analysis data of 617 male infertility patients undergoing treatment in our reproductive medical center were summarized in this paper to determine whether or not there is an association and correlation between these factors. chromosome karyotype abnormalities, Y chromosome microdeletions, cryptorchidism, urogenital system infections, cardiovascular and cerebrovascular diseases, diabetes mellitus, endocrinopathies, or abnormal reproductive hormone levels.
Methods
Nurses recorded the weights (in kilograms accurate to one decimal place) and heights (in centimeters accurate to one decimal place) of all subjects. Laboratory technicians used Makler counting chambers to perform routine semen analyses, applied Papanicolaou stain to ascertain sperm morphology, and classified the semen quality abnormalities in accordance with the experimental procedures and categories introduced in the Laboratory Manual for the Examination and Processing of Human Semen of the World Health Organization (WHO). The BMI was derived using the following formula: BMI = w/h 2 , where w represents weight (kg) and h represents height (m). 
BMI classification

Results
Frequency distribution of BMI, age, and semen parameters
Of the 617 study participants, 334, 220, and 63 were classified into the normal weight (54.1%), overweight (35.6%), and obese groups (10.2%), respectively (Table 1) .
Abnormal semen quality classifications in the 3 groups
The prevalence of asthenozoospermia, teratozoospermia, and asthenoteratozoospermia was much higher (12.7%-34.9%) than other abnormal categories; no oligozoospermia (0%) was noted in the 3 groups. The prevalence of abnormal semen quality was 66.9% in the 617 participants. The prevalence of abnormal semen quality in the normal weight, overweight, and obese groups was 65.2%, 66.8%, and 76.1%, respectively. A chi-square test showed no statistical difference among the 3 groups (P > 0.05), and no statistical differences existed between each two-group combination (P > 0.05). The details are listed in Table 2 and the Figure. 
Comparison of 8 parameters among the 3 groups using the Kruskal-Wallis H test
The Kruskal-Wallis H test indicated that a significant difference in BMI among the 3 groups (P < 0.01). Significant differences existed in age and progressive motility (P < 0.05); the other 5 parameters were not statistically different (P > 0.05). The data are listed in Table 1 .
Comparison of statistical differences between each two-group combination in the 3 groups by using the Mann-Whitney U test
Through a pairwise comparison of the BMI in the 3 groups, we detected statistical differences between all two-group combinations (P < 0.01). Through a pairwise comparison of age in the 3 groups, a statistical difference existed between the normal weight and obese groups and between the overweight and obese groups (P < 0.05); however, no statistical difference existed between the normal weight and overweight groups (P > 0.05).
With respect to the abstinence period, no statistical differences existed in pairwise comparisons of the 3 groups (P > 0.05). There were no statistical differences in semen volume, total sperm number, sperm concentration, and rate of normal sperm morphology using pairwise comparisons in the 3 groups (P > 0.05).
The progressive motility of the 3 groups was subjected to pairwise comparisons. There were statistical differences between all two-group comparisons (P < 0.05). 3.5. Spearman correlation analysis BMI was negatively related to sperm motility (P < 0.05), while it had no statistical correlation with semen volume, total sperm number, sperm concentration, or rate of normal morphology (P > 0.05).
Age was not correlated with semen parameters (semen volume, total sperm number, sperm concentration, sperm motility, and rate of normal morphology; P > 0.05).
Period of abstinence was negatively correlated with progressive motility (P < 0.01), while no correlations were found between the period of abstinence and semen volume, total sperm number, sperm concentration, motility, and rate of normal morphology (P > 0.05). 3.6. Multiple linear regression BMI, age, and abstinence period were selected as independent variables. Semen volume, total sperm number, sperm concentration, progressive motility, and the rate of normal morphology were chosen as dependent variables. After multiple linear regression analysis was performed, we showed that BMI (x 1 ), age (x 2 ), and days of abstinence (x 3 ) had a significant linear relationship with sperm motility (y = 48.223 − 0.315 × x 1 + 0.073 × x 2 − 1.699 × x 3 , P < 0.01). Abstinence period, BMI, and age influenced sperm motility (in that order). These 3 independent variables had no linear relationship with other semen parameters (P > 0.05).
Discussion
The prevalence of abnormal semen parameters was 66.9% among 617 infertility clinic patients based on the classification used in the current study. Asthenozoospermia, teratozoospermia, and asthenoteratozoospermia had the highest prevalence, which demonstrated that these 3 types of abnormalities were the main factors that caused semen quality to be reduced among male infertility patients, and also had an impact on male fertility. Furthermore, the prevalence of abnormal semen quality was 65%-76% in the normal weight, overweight, and obese groups. Although no statistical differences existed among the 3 groups, there was a tendency for the prevalence of abnormal semen parameters to increase with an increase in BMI.
In the normal weight, overweight, and obese groups, differences only existed in progressive motility (P < 0.05), which was one of the semen parameters evaluated. The median of the progressive motility in the 3 groups decreased as BMI increased. Sekhavat et al. (12) suggested that total sperm number, concentration, and motility in overweight and obese males were significantly lower than in males with a normal BMI. The rate of normal sperm morphology did not differ in any of the groups (12) . Nevertheless, Rybar et al. (13) reported that an elevated BMI did not have an influence on basic semen parameters. Mal-Ali et al. (13) concluded that BMI did not have an independent influence on sperm quality parameters based on a multivariable analysis. Our finding that BMI has an impact on sperm motility but no impact on sperm morphology is in agreement with Sekhavat et al. (12) . We concur with Rybar et al. (12) and Mal-Ali et al. (13) that BMI does not influence other sperm parameters.
We demonstrated that BMI is negatively correlated with sperm motility; however, it has no correlation with sperm volume, total sperm count, sperm concentration, and rate of normal morphology. Kort et al. (14) showed that BMI is negatively correlated with the total number of sperm cells with normal motility, while statistical differences existed among the BMI groups regarding the total number of sperm cells with normal motility (P < 0.05). Sekhavat et al. (15) reported a negative correlation between BMI and semen parameters. According to Paasch et al. (16) , only age correlated significantly with sperm parameters, although in patients aged 20-30 years, the total sperm number was negatively correlated with BMI. Håkonsen et al. (11) showed that BMI was inversely associated with sperm concentration, total sperm number, sperm morphology, and sperm motility after adjusting for potential confounding factors. Wogatzky et al. (17) concluded that although a single factor had a minor impact on sperm parameters, the combination of age, BMI, ejaculatory frequency, duration of sexual abstinence, and coffee intake had an adverse effect on sperm motility. MacDonald et al. (18) reported that there was no significant correlation between BMI and semen parameters, with the exception of the rate of normal sperm morphology (P = 0.024). Moreover, Hajshafiha et al. (19) showed that the likelihood of oligozoospermia was increased in males with a higher BMI. Obese males were 3.5-fold more likely to have oligozoospermia than males with normal a BMI, while BMI was not noticed to be correlated with mean numeric values of semen parameters, including sperm count, sperm morphology, and sperm (9), and Mormandi et al. (22) reported that BMI is not significantly correlated with routine semen parameters; however, the possibility of unconventional assessed semen parameters leading to decreased fertility cannot be excluded.
A discrepancy exists not only in independent research regarding the correlation between BMI and semen quality, but also in the following conclusions based on a metaanalysis. MacDonald et al. (18) collected 31 studies in a metaanalysis and concluded that no evidence existed to confirm that there was a relationship between increased BMI and semen parameters, especially with respect to sperm concentration and total sperm number. In 2013, a total of 21 studies and a sample of 13,077 males were included in the metaanalysis conducted by Sermoondade et al. (15) . It appeared that there was a J-shaped relationship between BMI categories and risk of oligozoospermia or azoospermia. Compared with normal weight males, the odds ratio was 1.15 (95% confidence interval [CI] = 0.93-1.43) for underweight, 1.11 (95% CI = 1.01-1.21) for overweight, 1.28 (95% CI = 1.06-1.55) for obese, and 2.04 (95% CI = 1.59-2.62) for morbidly obese men. Overweight and obesity were associated with an enhanced prevalence of azoospermia or oligozoospermia (15) .
Age and abstinence period affected seminal plasma volume and total sperm output, and also had an influence on total sperm number and sperm concentration based on the WHO criteria. Rybar et al. (13) and Eskandar et al. (23) concluded that there is a negative correlation between age and sperm motility. They also found that age had an impact on sperm concentration, motility, and semen quality. Our research showed that there was no correlation between age and semen volume, total sperm number, concentration, motility, and rate of normal morphology. A significant negative relationship existed between the abstinence period and progressive motility, whereas the abstinence period was not related to other semen parameters. Multiple linear regression analysis showed that abstinence period, BMI, and age were linearly related to sperm progressive motility (P < 0.01), in that order. The above 3 independent variables had no linear relationship with other sperm parameters.
We reviewed several studies (11, 17, 20, 24, 25) to determine the mechanism by which BMI influenced semen quality and male fertility. This mechanism comprises dysfunction of the hypothalamus-pituitarygonadal axis, abnormal levels of reproductive and related hormones (INH-B, FSH, LH, E 2 , PRL, leptin, T, SHBG, and AMH), dysfunction of male sexual accessory glands (neutral alpha-glucoside enzyme and seminal plasma fructose), and living and dietary habits (coffee intake volume) in overweight or obese patients. An increase in weight or BMI might have no apparent impact or damage on the sperm output from the testes while it influences sperm maturity, motility, or DNA damage. Indeed, BMI, abstinence period, and coffee intake might improve semen quality and enhance male fertility.
In conclusion, there is disagreement as to whether or not BMI has an influence on semen parameters and semen quality; however, our research demonstrated that the most adversely affected susceptible factor among the semen parameters was sperm motility. Indeed, statistical differences existed in sperm motility among the different BMI groups. BMI and abstinence period were negatively related to sperm motility. Sperm motility decreased with an increase in BMI. Therefore, BMI is a risk factor that influences semen quality and reduces male fertility.
